Share This Page
Avobenzone; octinoxate; oxybenzone - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for avobenzone; octinoxate; oxybenzone and what is the scope of patent protection?
Avobenzone; octinoxate; oxybenzone
is the generic ingredient in one branded drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for avobenzone; octinoxate; oxybenzone
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | avobenzone; octinoxate; oxybenzone at DailyMed |
Recent Clinical Trials for avobenzone; octinoxate; oxybenzone
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Food and Drug Administration (FDA) | Phase 1 |
| Spaulding Clinical Research LLC | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for avobenzone; octinoxate; oxybenzone
US Patents and Regulatory Information for avobenzone; octinoxate; oxybenzone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare Llc | SHADE UVAGUARD | avobenzone; octinoxate; oxybenzone | LOTION;TOPICAL | 020045-001 | Dec 7, 1992 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for avobenzone; octinoxate; oxybenzone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Llc | SHADE UVAGUARD | avobenzone; octinoxate; oxybenzone | LOTION;TOPICAL | 020045-001 | Dec 7, 1992 | 4,387,089 | ⤷ Start Trial |
| Bayer Healthcare Llc | SHADE UVAGUARD | avobenzone; octinoxate; oxybenzone | LOTION;TOPICAL | 020045-001 | Dec 7, 1992 | 4,522,807 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Avobenzone, Octinoxate, and Oxybenzone: Market Dynamics and Financial Trajectory
Avobenzone, octinoxate, and oxybenzone represent a significant segment within the sunscreen and personal care product market, primarily driven by their efficacy as UV filters. The market for these ingredients is influenced by regulatory landscapes, consumer demand for sun protection, and the development of alternative or complementary UV filtering technologies. Financial performance is tied to production costs, market penetration, and evolving consumer preferences regarding product safety and environmental impact.
What is the Market Size and Growth Trajectory for Avobenzone, Octinoxate, and Oxybenzone?
The global market for sunscreen ingredients, including avobenzone, octinoxate, and oxybenzone, is substantial and projected for continued growth. Market valuation for the broader sunscreen ingredients sector is estimated to reach $1.8 billion by 2027, exhibiting a compound annual growth rate (CAGR) of approximately 4.2% from 2020 to 2027. [1] While specific market share data for individual ingredients like avobenzone, octinoxate, and oxybenzone is often proprietary and integrated within broader ingredient categories, their widespread use in broad-spectrum sunscreens indicates a significant contribution to this overall market.
Growth is underpinned by increasing consumer awareness of the harmful effects of UV radiation, including premature skin aging and skin cancer. This awareness translates into higher demand for sun protection products. Furthermore, expanding distribution channels, particularly in emerging economies, and the integration of UV protection into daily wear cosmetics contribute to market expansion.
However, growth is tempered by evolving regulatory scrutiny and public perception regarding the safety and environmental impact of certain chemical UV filters. This has led to a nuanced market dynamic where established ingredients face competition from newer formulations and mineral-based alternatives.
What are the Primary Applications and Demand Drivers for These UV Filters?
Avobenzone, octinoxate, and oxybenzone are primarily used as active ingredients in sunscreen formulations. Their function is to absorb and dissipate ultraviolet radiation, preventing it from penetrating the skin.
- Avobenzone: This is a broad-spectrum UVA and UVB absorber, particularly effective against UVA rays, which are associated with skin aging. It is a staple in many broad-spectrum sunscreens due to its ability to protect against both types of harmful UV radiation.
- Octinoxate: This UVB absorber is widely used for its cost-effectiveness and ability to stabilize avobenzone. It is a key component in many sunscreen and anti-aging products.
- Oxybenzone: This is another broad-spectrum UV filter, absorbing both UVA and UVB radiation. It is frequently used in combination with other UV filters to achieve optimal SPF and broad-spectrum coverage.
Demand Drivers:
- Increased UV Awareness: Growing understanding of the link between UV exposure and skin damage, including sunburn, premature aging, and skin cancer, drives demand for effective sun protection. Public health campaigns and medical recommendations reinforce this.
- Product Innovation: Formulators continuously develop new sunscreen products with improved textures, aesthetics, and combined benefits (e.g., hydration, anti-aging), which incorporate these filters.
- Cosmeceutical Integration: The trend of incorporating UV protection into daily skincare and makeup products (e.g., moisturizers, foundations) broadens the application scope for these ingredients.
- SPF Standards and Labeling: Regulatory requirements for SPF and broad-spectrum labeling necessitate the use of effective UV filters.
What is the Regulatory Landscape Impacting Avobenzone, Octinoxate, and Oxybenzone?
The regulatory environment is a critical factor shaping the market for avobenzone, octinoxate, and oxybenzone. Specific regions have implemented or are considering restrictions based on environmental and health concerns.
- Hawaii: In 2018, Hawaii became the first U.S. state to ban the sale of sunscreens containing oxybenzone and octinoxate starting in 2021. The legislation, Bill 2174, cited concerns that these chemicals contribute to coral reef degradation. [2]
- Palau: The Republic of Palau enacted a similar ban on sunscreens containing oxybenzone and octinoxate in 2018, effective from 2020. This ban is also attributed to protecting marine ecosystems. [3]
- Key West, Florida: In 2019, Key West voters approved a ban on sunscreens containing oxybenzone and octinoxate. [4]
- European Union (EU): While not banned, the EU has established concentration limits for UV filters. For oxybenzone, the maximum authorized concentration is 10%. [5] For octinoxate, the maximum authorized concentration is also 10%. [5] For avobenzone, the maximum authorized concentration is 5%. [5]
- United States Food and Drug Administration (FDA): The FDA has re-evaluated the safety of over-the-counter (OTC) sunscreen ingredients. In a 2019 proposed rule, the FDA considered avobenzone, octinoxate, and oxybenzone as ingredients needing additional data to be generally recognized as safe and effective (GRASE). [6] This means that while they are currently permitted, further studies are required to confirm their safety for widespread OTC use, potentially leading to future restrictions or data requirements. Specifically, concerns have been raised regarding the systemic absorption of these ingredients. [6]
These regulatory actions, particularly bans and proposed restrictions, create market uncertainty and incentivize formulators to explore alternatives, impacting the demand for these specific UV filters.
What are the Environmental and Health Concerns Associated with These Ingredients?
Concerns regarding the environmental persistence and potential health effects of avobenzone, octinoxate, and oxybenzone are influencing consumer choices and regulatory decisions.
Environmental Concerns:
- Coral Reef Degradation: Oxybenzone and octinoxate have been identified as contributors to coral bleaching and damage. Studies have indicated that even low concentrations can harm coral larvae and adult corals. [2, 3] This has been a primary driver for bans in reef-sensitive regions.
- Aquatic Toxicity: Beyond coral reefs, these chemicals can pose risks to other marine organisms.
Health Concerns:
- Endocrine Disruption: Oxybenzone, in particular, has been flagged for its potential endocrine-disrupting properties. Studies have suggested it may interfere with hormone systems, although the implications for human health at typical exposure levels are still under investigation. [6]
- Systemic Absorption: The FDA's 2019 proposed rule noted that avobenzone, octinoxate, and oxybenzone are absorbed into the bloodstream. While systemic absorption does not automatically equate to harm, it necessitates further research to understand the potential long-term health effects. [6]
- Allergic Reactions and Skin Sensitization: Some individuals may experience allergic reactions or skin sensitivity to these ingredients, although this is not unique to these specific UV filters.
These concerns, supported by scientific research, are fueling a demand for "reef-safe" and "clean" sunscreen formulations, pushing the market towards mineral-based filters (zinc oxide, titanium dioxide) and alternative chemical filters perceived as safer.
What is the Competitive Landscape and the Rise of Alternatives?
The market for UV filters is dynamic, with established ingredients facing increasing competition from both newer chemical filters and mineral-based alternatives.
Established Players:
- Avobenzone, Octinoxate, Oxybenzone: These remain widely used due to their cost-effectiveness and proven efficacy, particularly in regions with less stringent regulations. Manufacturers of these ingredients operate in a mature market, focusing on consistent supply and competitive pricing.
Emerging Alternatives:
- Mineral Filters: Zinc oxide and titanium dioxide are gaining significant market share. They are considered safe and effective, with no widespread environmental concerns. Their main drawbacks have historically been cosmetic elegance (whitening effect), but advancements in micronization and nanotechnology have improved their texture and transparency.
- Newer Generation Chemical Filters: Several newer chemical UV filters have been approved in various regions, offering improved photostability, broader spectrum protection, and potentially better safety profiles. Examples include DHHB (Diethylamino Hydroxybenzoyl Hexyl Benzoate) and Bemotrizinol (Tinosorb S), which are approved in Europe and other markets. These filters often offer enhanced photostability, meaning they degrade less upon UV exposure, providing more consistent protection.
- Hybrid Formulations: Many products combine mineral and chemical filters to leverage the benefits of both, achieving broad-spectrum protection with improved cosmetic feel.
Competitive Dynamics:
- Innovation: Companies are investing in R&D to develop novel UV filters with superior performance, safety, and environmental profiles.
- Marketing and Consumer Perception: Brands are capitalizing on "reef-safe," "eco-friendly," and "natural" messaging, which often favors mineral filters or specific chemical filter combinations.
- Regulatory Arbitrage: Manufacturers must navigate differing regulations across key markets, which can influence product formulation and market access.
What is the Financial Trajectory and Profitability Outlook for Producers?
The financial trajectory for producers of avobenzone, octinoxate, and oxybenzone is complex, influenced by multiple factors.
- Mature Market Pricing: As established ingredients, their pricing is often competitive. Profitability relies on high-volume production and efficient manufacturing processes.
- Volume Dependence: Demand remains high globally due to their widespread use, ensuring a consistent revenue stream. However, the increasing adoption of alternatives in key markets poses a risk to long-term volume growth.
- R&D Investment in Alternatives: Companies producing these traditional filters may also be investing in or acquiring capabilities for newer, more sustainable UV filters to diversify their portfolios and mitigate regulatory risks.
- Impact of Regulatory Bans: Bans in specific regions directly reduce demand and necessitate reformulation efforts by sunscreen manufacturers, impacting the sales of banned ingredients. This can lead to write-downs or reduced production capacity for specific chemicals.
- Cost of Production: The cost of raw materials, energy, and compliance with environmental regulations affects profit margins.
- Emerging Market Growth: Continued demand from emerging economies, where regulatory oversight may be less stringent or consumer preferences are still developing, provides a buffer for producers.
Profitability Outlook:
The outlook is characterized by stable to moderate growth in the short to medium term, primarily driven by demand in less regulated markets and their continued use in mass-market products. However, long-term profitability faces pressure from:
- Substitution by Alternatives: The increasing consumer and regulatory preference for mineral filters and newer chemical filters will likely lead to a gradual erosion of market share.
- Increased Regulatory Pressure: Further studies and potential reclassifications by regulatory bodies like the FDA could lead to more restrictions.
- Brand Differentiation: Brands actively marketing "clean" or "reef-safe" products will increasingly avoid these ingredients, limiting their inclusion in premium and specialty formulations.
Producers who can adapt by offering a diversified portfolio of UV filters, including newer generations and mineral options, are better positioned for sustained financial success.
Key Takeaways
Avobenzone, octinoxate, and oxybenzone remain significant components in the global sunscreen market, driven by their broad-spectrum UV protection capabilities and cost-effectiveness. However, their market trajectory is increasingly shaped by environmental and health concerns, leading to regulatory restrictions in key regions like Hawaii, Palau, and Key West, and ongoing scrutiny by the FDA. These concerns, coupled with the rise of mineral-based alternatives (zinc oxide, titanium dioxide) and newer generation chemical filters, are creating a competitive landscape that pressures the long-term growth of these established ingredients. Producers face a complex financial outlook, balancing stable demand from emerging markets and mass-market applications against the accelerating shift towards alternatives in developed economies. Companies that can pivot to a diversified UV filter portfolio, including innovative and sustainable options, are best positioned for future market relevance and profitability.
FAQs
-
Are avobenzone, octinoxate, and oxybenzone banned worldwide? No, these ingredients are not banned worldwide. However, several specific regions, including Hawaii, Palau, and Key West, have enacted bans primarily due to environmental concerns related to coral reefs. Regulatory bodies in other regions, such as the U.S. FDA and the EU, have established usage limits and are evaluating their safety.
-
What are the primary alternatives to avobenzone, octinoxate, and oxybenzone in sunscreens? The primary alternatives include mineral UV filters, namely zinc oxide and titanium dioxide, which are considered reef-safe and have a favorable safety profile. Newer generation chemical UV filters, such as DHHB and Bemotrizinol, are also gaining traction due to their improved photostability and perceived safety.
-
What specific environmental concerns are associated with octinoxate and oxybenzone? Octinoxate and oxybenzone are primarily associated with contributing to coral reef degradation, including coral bleaching and damage to coral larvae. They have also been linked to aquatic toxicity for other marine organisms.
-
Does the U.S. FDA consider avobenzone, octinoxate, and oxybenzone safe for sunscreen use? In 2019, the U.S. FDA proposed that avobenzone, octinoxate, and oxybenzone need further data to be generally recognized as safe and effective (GRASE) for OTC sunscreen products. Concerns include their systemic absorption into the bloodstream, prompting a need for additional safety research before their status is definitively confirmed.
-
How are manufacturers adapting to the changing market demands for UV filters? Manufacturers are adapting by investing in the development and production of alternative UV filters, including mineral-based options and newer chemical filters with better environmental and safety profiles. They are also reformulating products to meet "reef-safe" and "clean beauty" labeling trends, and diversifying their product portfolios to cater to a wider range of consumer and regulatory preferences.
Citations
[1] Grand View Research. (2020). Sunscreen Ingredients Market Size, Share & Trends Analysis Report By Type (Chemical, Mineral), By Application (Sunscreens, Daily Wear Cosmetics, Others), By Region, And Segment Forecasts, 2020-2027. Grand View Research.
[2] Hawaii State Legislature. (2018). SB2174 SD2 HD1 CD1. Hawaii State Legislature.
[3] Republic of Palau. (2018). Protecting Our Reefs Act.
[4] City of Key West. (2019). Ordinance No. 19-07. City of Key West.
[5] European Commission. (n.d.). Cosmetic Products Regulation (EC) No 1223/2009. European Commission.
[6] U.S. Food and Drug Administration. (2019). Safety and Efficacy of Sunscreen Active Ingredients of Over-the-Counter (OTC) Sunscreen Products Proposed Rule. Federal Register, 84(100), 25560–25637.
More… ↓
